Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 9,072 AKTX shares, $71.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 9,072 | $71.7K |
| Dec 19, 2025 | Akari Therapeutics Plc (AKTX) | Purchase | 618,658 | n/a |
| Mar 24, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 175,000 | n/a |
| Mar 10, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 446,428 | $500.0K |
| Dec 3, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 419,286,000 | $503.1K |
| Jul 2, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 10,000,000 | n/a |
| Jun 4, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 1,326,258,000 | $1.19M |